Pavel Svoboda

Ostrava, MO, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Persistence of advanced therapies in patients with ulcerative colitis: real-world data from the nationwide CREdIT registry.

Persistence of advanced therapies in patients with ulcerative colitis: real-world data from the nationwide CREdIT registry.

Journal: Therapeutic advances in gastroenterology

Published: November 18, 2025

Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study.

Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study.

Journal: Journal of Crohn's & colitis

Published: March 22, 2022

Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study.

Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study.

Journal: Therapeutic advances in gastroenterology

Published: February 27, 2021

Bone metabolism in inflammatory bowel diseases 1.

Bone metabolism in inflammatory bowel diseases 1.

Journal: Vnitrni lekarstvi

Published: December 31, 2020

Bone Metabolism in Inflammatory Bowel Diseases 2.

Bone Metabolism in Inflammatory Bowel Diseases 2.

Journal: Vnitrni lekarstvi

Published: December 31, 2020

Infliximab pharmacokinetics monitoring in inflammatory bowel disease.

Infliximab pharmacokinetics monitoring in inflammatory bowel disease.

Journal: Vnitrni lekarstvi

Published: January 01, 2020

Pancreatic Solid Focal Lesions: Differential Diagnosis between Autoimmune Pancreatitis and Pancreatic Cancer.

Pancreatic Solid Focal Lesions: Differential Diagnosis between Autoimmune Pancreatitis and Pancreatic Cancer.

Journal: Digestive diseases (Basel, Switzerland)

Published: March 12, 2019

Effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting in patients with Crohn's disease or ulcerative colitis.

Effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting in patients with Crohn's disease or ulcerative colitis.

Journal: Journal of drug assessment

Published: January 17, 2019

Adiponectin in patients with metabolic syndrome and diseases of the liver, bile ducts and pancreas

Adiponectin in patients with metabolic syndrome and diseases of the liver, bile ducts and pancreas

Journal: Vnitrni lekarstvi

Published: January 17, 2018

A contribution to the differential diagnostics of sclerosing cholangitides

A contribution to the differential diagnostics of sclerosing cholangitides

Journal: Vnitrni lekarstvi

Published: February 23, 2017

Chronic pancreatitis diagnosed after the first attack of acute pancreatitis

Chronic pancreatitis diagnosed after the first attack of acute pancreatitis

Journal: Vnitrni lekarstvi

Published: May 13, 2016

Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis.

Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis.

Journal: Scandinavian journal of gastroenterology

Published: March 23, 2016

Showing 1-12 of 20

Last Updated: 09/26/2026